Loading...
MAP3K13 Antibody

36205

MAP3K13 Antibody

MAP3K13 Antibody (catalogue number 36205) is a rabbit-derived primary antibody validated for Immunohistochemistry, reactive with Human samples. It targets Mitogen-activated protein kinase kinase kinase 13 (MAP3K13): Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Supplied as 100ul at ₪1,301.17; the final price is confirmed on your quote and the lot certificate of analysis ships with the order.

Primary AntibodyHostRabbit
Host / source
Rabbit
Reactivity
Human
Applications
Immunohistochemistry
UniProt ID
O43283
Gene
MAP3K13
Target organism
Homo sapiens
Catalogue number
36205
Brand
LABO Scientific
Storage
Store at -20°C for long term preservation (recommended). Store at 4°C for short term use.

Target background

Target: Mitogen-activated protein kinase kinase kinase 13 (MAP3K13) · Homo sapiens

Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B

Subcellular location: Cytoplasm; Membrane

Tissue specificity: Expressed in the adult brain, liver, placenta and pancreas, with expression strongest in the pancreas

Sequence length: 966 aa · 108296 Da

Protein background from UniProtKB, licensed under CC BY 4.0. Describes the target antigen, not this product.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Storage
Store at -20°C for long term preservation (recommended). Store at 4°C for short term use.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.